Comparative Study of Short-Term Efficacy and Safety of Mitomycin versus Lobaplatin for Hyperthermic Intraperitoneal Chemotherapy after Radical Surgery in Colorectal Cancer with High-Risk Factors for Peritoneal Carcinomatosis: A Propensity Score Matching Analysis
Background: The drug selection of radical surgery (RS), with hyperthermic intraperitoneal chemotherapy (HIPEC), in pT4 colorectal cancer (CRC) remains controversial. Methods: Adverse events after HIPEC were estimated by common terminology criteria for adverse events version 5.0. The efficacy was eva...
Main Authors: | Xikai Guo, Yao Lin, Chu Shen, Yuan Li, Fan Xiang, Tuo Ruan, Xinyu Zeng, Jianbo Lv, Kaixiong Tao, Chuanqing Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/2/114 |
Similar Items
-
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in management of peritoneal carcinomatosis: Single center experience in Korea
by: Hee Ju Lee, et al.
Published: (2019-12-01) -
Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy
by: Young Song, et al.
Published: (2023-10-01) -
The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
by: Roxan F.C.P.A. Helderman, et al.
Published: (2020-07-01) -
The impact of hyperthermic intraperitoneal chemotherapy and cytoreductive surgery on clinical outcomes and quality of life of patients with peritoneal carcinomatosis
by: Oleksandr Vadymovych Bondar, et al.
Published: (2021-12-01) -
Advances in the Treatment of Colorectal Cancer with Peritoneal
Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal
Chemotherapy
by: Youngbae Jeon, et al.
Published: (2023-12-01)